Toxicity and biodistribution comparison of functionalized nanodiamonds, quantum dot nanocarbons and gold nanoparticles

Introduction Nanomaterials are extensively utilized in applications ranging from electronics to biomedical therapies; however, their widespread use has prompted concerns about potential toxicity in humans. Understanding the biodistribution and toxicity profiles of nanoparticles is crucial for their safe application. Methods This study assessed the dose-dependent toxicity and biodistribution of unconjugated nanodiamonds, nanobody-conjugated nanodiamonds, gold nanoparticles, and quantum dot nanocarbons in 22 female C57BL/6 mice. Nanoparticles were intravenously administered at concentrations of 5, 10, 20, and 40 mg/kg. Samples were collected at 2, 24, and 96 hours post-administration to evaluate tolerability, immune responses, and biodistribution patterns. Results Unconjugated nanodiamonds showed favorable tolerability, eliciting minimal inflammatory responses and significantly lower memory T cell activation compared to gold nanoparticles and quantum dot nanocarbons. Nanobody-conjugated nanodiamonds triggered moderate inflammation at 2 hours post-dosing. Specifically, CD69 expression in CD8 + T cells was highest in the gold nanoparticle group (mean: 0.40 ± 0.16) and lowest in the unconjugated nanodiamond group (mean: 0.12 ± 0.09). CD25 expression was most elevated in quantum dot nanocarbons (mean: 0.23 ± 0.04) and lowest in nanobody-conjugated nanodiamonds (mean: 0.09 ± 0.04). Total T cells were highest in the nanobody-conjugated group (mean: 49.10% ± 6.99) and lowest in the unconjugated nanodiamond group (mean: 40.70% ± 8.10). Nanodiamonds primarily accumulated in the heart, whereas gold nanoparticles localized mainly in the left lung, and quantum dot nanocarbons predominantly persisted in the kidney, liver, blood, and heart. Discussion These results indicate that nanodiamonds exhibit favorable tolerability and controlled immune responses compared to gold nanoparticles and quantum dot nanocarbons, highlighting their potential as safer nanomaterials for biomedical applications.

Authors

Institutions

Publication Details

Journal
Frontiers in Nanotechnology
Published
2025-04-14
DOI
https://doi.org/10.3389/fnano.2025.1512622
Citations
18
Primary Topic
Graphene and Nanomaterials Applications
Type
article
Field-Weighted Citation Impact
12.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Toxicity and biodistribution comparison of functionalized nanodiamonds, quantum dot nanocarbons and gold nanoparticles

Kam W. Leong, Elena Alexander
18 citations
Frontiers in Nanotechnology
Graphene and Nanomaterials Applications
12.13
article

Toxicity and biodistribution comparison of functionalized nanodiamonds, quantum dot nanocarbons and gold nanoparticles

Kam W. Leong, Elena Alexander
article en
18 citations

Abstract

Introduction Nanomaterials are extensively utilized in applications ranging from electronics to biomedical therapies; however, their widespread use has prompted concerns about potential toxicity in humans. Understanding the biodistribution and toxicity profiles of nanoparticles is crucial for their safe application. Methods This study assessed the dose-dependent toxicity and biodistribution of unconjugated nanodiamonds, nanobody-conjugated nanodiamonds, gold nanoparticles, and quantum dot nanocarbons in 22 female C57BL/6 mice. Nanoparticles were intravenously administered at concentrations of 5, 10, 20, and 40 mg/kg. Samples were collected at 2, 24, and 96 hours post-administration to evaluate tolerability, immune responses, and biodistribution patterns. Results Unconjugated nanodiamonds showed favorable tolerability, eliciting minimal inflammatory responses and significantly lower memory T cell activation compared to gold nanoparticles and quantum dot nanocarbons. Nanobody-conjugated nanodiamonds triggered moderate inflammation at 2 hours post-dosing. Specifically, CD69 expression in CD8 + T cells was highest in the gold nanoparticle group (mean: 0.40 ± 0.16) and lowest in the unconjugated nanodiamond group (mean: 0.12 ± 0.09). CD25 expression was most elevated in quantum dot nanocarbons (mean: 0.23 ± 0.04) and lowest in nanobody-conjugated nanodiamonds (mean: 0.09 ± 0.04). Total T cells were highest in the nanobody-conjugated group (mean: 49.10% ± 6.99) and lowest in the unconjugated nanodiamond group (mean: 40.70% ± 8.10). Nanodiamonds primarily accumulated in the heart, whereas gold nanoparticles localized mainly in the left lung, and quantum dot nanocarbons predominantly persisted in the kidney, liver, blood, and heart. Discussion These results indicate that nanodiamonds exhibit favorable tolerability and controlled immune responses compared to gold nanoparticles and quantum dot nanocarbons, highlighting their potential as safer nanomaterials for biomedical applications.

Frontiers in NanotechnologyVol. 7
Columbia University (US)
Openalex Percentile: Top 1%
Graphene and Nanomaterials Applications
12.13
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.